Vitamin e forms in Alzheimer's disease: A review of controversial and clinical experiences

Critical Reviews in Food Science and Nutrition

Volumn 50, Issue 5, 2010, Pages 414-419

  Usoro, Owoedimo B ^a   Mousa, Shaker A ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Alpha tocopherol; Antioxidants; Delta tocopherol; Gammatocopherol; Neurodegenerative disease; Oxidative stress; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT;

ALZHEIMER DISEASE; COGNITIVE DEFECT; HUMAN; REVIEW;

ALZHEIMER DISEASE; ANTIOXIDANTS; COGNITION DISORDERS; HUMANS; VITAMIN E;

EID: 77950885346     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408390802304222     Document Type: Review

References (48)

1. Ames, B. N., Shigenaga, M. K. and Hagen, T. M. (1993). Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci. 90(17): 7915-7922.
2. Aydemir, O., Celebi, S., Yilmaz, T., Yekeler, H. and Kukner, A. S. (2004). Protective effects of vitamin E forms (alpha-tocopherol, gamma-tocopherol and d-alpha-tocopherol polyethylene glycol 1000 succinate) on retinal edema during ischemia-reperfusion injury in the guinea pig retina. Int Ophthalmol. 25(5-6):283-289.
3. Baker, H., Handelman, G. J., Short, S., Machlin, L. J., Bhagavan, H. N., Dratz, E. A. and Frank, O. (1986). Comparison of plasma alpha and gamma tocopherol levels following chronic oral administration of either all-rac-alpha-tocopheryl acetate or RRR-alpha-tocopheryl acetate in normal adult male subjects. Am J Clin Nutr. 43(3):382-387.
4. Burton, G. W., Joyce, A. and Ingold, K. U. (1983). Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys. 221(1):281-290.
5. Butterfield, D. A., Castegna, A., Drake, J., Scapagnini, G. and Calabrese, V. (2002). Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutr Neurosci. 5(4):229-239.
6. Canevari, L., Abramov, A. Y. and Duchen, M. R. (2004). Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem Res. 29(3):637-650.
7. Christen, S., Woodall, A. A., Shigenaga, M. K., Southwell-Keely, P. T., Duncan, M. W. and Ames, B. N. (1997). gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci. 94(7):3217-3222.
8. Clarke, M. W., Ward, N. C., Wu, J. H., Hodgson, J. M., Puddey, I. B. and Croft, K. D. (2006). Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes. Am J Clin Nutr. 83(1):95-102.
9. Cooney, R. V., Franke, A. A., Harwood, P. J., Hatch-Pigott, V., Custer, L. J. and Mordan, L. J. (1993). Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc Natl Acad Sci. 90(5):1771-1775.
10. Coyle, J. T. and Puttfarcken, P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262(5134):689-695.
11. Elmadfa, I. and Park, E. (1999). Impact of diets with corn oil or olive/sunflower oils on DNA damage in healthy young men. Eur J Nutr. 38(6):286-292.
12. Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C. and Breteler, M. M. (2002). Dietary intake of antioxidants and risk of Alzheimer disease. Jama. 287(24):3223-3229.
13. Evans, P. H. (1993). Free radicals in brain metabolism and pathology. Br Med Bull. 49(3):577-587.
14. Floyd, R. A. and Hensley, K. (2002). Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging. 23(5):795-807.
15. Food and Nutrition Board, I. o. M. ed. (2000). Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington DC: National Acaedemy Press.
16. Gackowski, D., Rozalski, R., Siomek, A., Dziaman, T., Nicpon, K., Klimarczyk, M., Araszkiewicz, A. and Olinski, R. (2008). Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia. J Neurol Sci. 266(1-2):57-62.
17. Halliwell, B. (1999). Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res. 31(4):261-272.
18. Handelman, G. J., Epstein, W. L., Peerson, J., Spiegelman, D., Machlin, L. J. and Dratz, E. A. (1994). Human adipose alpha-tocopherol and gamma-tocopherol kinetics during and after 1 y of alpha-tocopherol supplementation. Am J Clin Nutr. 59(5):1025-1032.
19. Handelman, G. J., Machlin, L. J., Fitch, K., Weiter, J. J. and Dratz, E. A. (1985). Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. J Nutr. 115(6):807-813.
20. Helzlsouer, K. J., Huang, H. Y., Alberg, A. J., Hoffman, S., Burke, A., Norkus, E. P., Morris, J. S. and Comstock, G. W. (2000). Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 92(24):2018-2023.
21. Huang, H. Y., Alberg, A. J., Norkus, E. P., Hoffman, S. C., Comstock, G. W. and Helzlsouer, K. J. (2003). Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol. 157(4):335-344.
22. Huang, H. Y. and Appel, L. J. (2003). Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr. 133(10):3137-3140.
23. Jenner, P. (1994). Oxidative damage in neurodegenerative disease. Lancet. 344(8925):796-798.
24. Jenner, P. (2003). Oxidative stress in Parkinson's disease. Ann Neurol. 53 Suppl 3: S26-36; discussion S36-28.
25. Jiang, Q., Elson-Schwab, I., Courtemanche, C. and Ames, B. N. (2000). gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci. 97(21):11494-11499.
26. Kamal-Eldin, A. and Appelqvist, L. A. (1996). The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids. 31(7):671-701.
27. Knight, J. A. (1997). Reactive oxygen species and the neurodegenerative disorders. Ann Clin Lab Sci. 27(1):11-25.
28. Lodge, J. K., Ridlington, J., Leonard, S., Vaule, H. and Traber, M. G. (2001). Alpha- and gamma-tocotrienols are metabolized to carboxyethyl- hydroxychroman derivatives and excreted in human urine. Lipids. 36(1):43-48.
29. Martin, A., Janigian, D., Shukitt-Hale, B., Prior, R. L. and Joseph, J. A. (1999). Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations. Brain Res. 845(1):50-59.
30. McIntyre, B. S., Briski, K. P., Gapor, A. and Sylvester, P. W. (2000). Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med. 224(4):292-301.
31. McLaughlin, P. J. and Weihrauch, J. L. (1979). Vitamin E content of foods. J Am Diet Assoc. 75(6):647-665.
32. Mirra, S. (1997). Alzheimer's Disease and Other Dementias: Neuropathological Considerations. Washington, DC: American Psychiatric Publishing, Inc.
33. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C. and Wilson, R. S. (2002). Vitamin E and cognitive decline in older persons. Arch Neurol. 59(7):1125-1132.
34. Mortimer, J. (1997). Is Alzheimer's Disease a Lifelong Illness? Risk Factors for Pathological and Clinical Disease. Washington, DC: American Psychiatric Publishing, Inc.
35. Moyad, M. A., Brumfield, S. K. and Pienta, K. J. (1999). Vitamin E, alpha- and gamma-tocopherol, and prostate cancer. Semin Urol Oncol. 17(2):85-90.
36. Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., Pfeiffer, E., Sano, M., van Dyck, C. H. and Thal, L. J. (2005). Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 352(23):2379-2388.
37. Puglielli, L., Tanzi, R. E. and Kovacs, D. M. (2003). Alzheimer's disease: the cholesterol connection. Nat Neurosci. 6(4):345-351.
38. Ricciarelli, R., Argellati, F., Pronzato, M. A. and Domenicotti, C. (2007). Vitamin E and neurodegenerative diseases. Mol Aspects Med. 28(5-6):591-606.
39. Rinaldi, P., Polidori, M. C., Metastasio, A., Mariani, E., Mattioli, P., Cherubini, A., Catani, M., Cecchetti, R., Senin, U. and Mecocci, P. (2003). Plasma anti-oxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging. 24(7):915-919.
40. Rota, C., Rimbach, G., Minihane, A. M., Stoecklin, E. and Barella, L. (2005). Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties. Nutr Neurosci. 8(1):21-29.
41. Saldeen, T., Li, D. and Mehta, J. L. (1999). Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol. 34(4):1208-1215.
42. Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., Schneider, L. S. and Thal, L. J. (1997). A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 336(17):1216-1222.
43. Selkoe, D. J. (2005). Defining molecular targets to prevent Alzheimer disease. Arch Neurol. 62(2):192-195.
44. Sies, H. (2007). Biological redox systems and oxidative stress. Cell Mol Life Sci. 64(17):2181-2188.
45. Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K. and Perry, G. (2000). Oxidative stress in Alzheimer's disease. Biochim Biophys Acta. 1502(1):139-144.
46. St George-Hyslop, P. H. (2000). Piecing together Alzheimer's. Sci Am. 283(6):76-83.
47. Wagner, K. H., Kamal-Eldin, A. and Elmadfa, I. (2004). Gamma-tocopherol-an underestimated vitamin? Ann Nutr Metab. 48(3):169-188.
48. Williamson, K. S., Gabbita, S. P., Mou, S., West, M., Pye, Q. N., Markesbery, W. R., Cooney, R. V., Grammas, P., Reimann-Philipp, U., Floyd, R. A. and Hensley, K. (2002). The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide. 6(2):221-227.